According to a new market report published by Lucintel, the future of the
non-invasive prenatal testing (NIPT) market looks promising with opportunities in trisomy, aneuploidy, and microdeletion. The global non-invasive prenatal testing market is expected to grow with a CAGR of 14% from 2020 to 2025. The major drivers for this market are high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.
To download report brochure, please go to https://www.lucintel.com/non-invasive-prenatal-testing-market.aspx and click "download brochure" tab from the menu
Non-invasive prenatal testing (NIPT) is a method for determining the risk that the fetus will be born with certain genetic abnormalities. This testing analyzes small fragments of DNA that are circulating in a pregnant woman's blood. In this market, trisomy, aneuploidy, and microdeletion are the major application segments. Lucintel forecasts that trisomy will remain the largest application segment over the forecast period due to factors, such as increasing maternal age and the rising incidence of chromosomal abnormalities.
Within this market, diagnostic laboratories will remain the largest end user segment over the forecast period due to factors, such as the implementation of initiatives by diagnostic laboratories to provide safe and effective prenatal tests and rising incidence of chromosomal abnormalities.
Asia Pacific will remain the fastest grwoing region over the forecast period due to developing healthcare infrastructure, rising awareness of programs & conferences, and rising focus of prominent players on expanding their presence in this region.
Illumina, Thermo Fisher Scientific, GE Healthcare, BGI, Agilent Technologies, F. Hoffmann-La Roche, PerkinElmer, Laboratory Corporation of America Holdings, Natera, and Yourgene Health are among the major suppliers in the global non-invasive prenatal testing market.
Lucintel, a leading global strategic consulting and
market research firm, has analyzed growth opportunities in the global non-invasive prenatal testing market by product, method, application, end user, and region. Lucintel has prepared a comprehensive research report titled “
Growth Opportunities in the Global Non-Invasive Prenatal Testing Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global non-invasive prenatal testing market by product, method, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Consumables
-
Reagents
-
Ultrasound
-
NGS
-
PCR
-
Microarray
By Method [Value ($ Million) shipment analysis for 2014 – 2025]:
-
cfDNA
-
Biochemical Markers
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Trisomy
-
Aneuploidy
-
Microdeletion
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Hospitals
-
Diagnostic Laboratories
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
United States
-
Canada
-
Mexico
-
United Kingdom
-
Spain
-
Germany
-
France
This more than 150 page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.
